Table 2.

Unadjusted and Adjusted Risk of HCC in Patients with Nonalcoholic Steatohepatitis vs All Other Etiologies.

	OR (95% CI)	Adjusted OR (95% CI)
NASH with T2DM vs NASH without T2DM	1.68 (1.52–1.86)	1.50 (1.35–1.66)
NASH with T2DM vs other etiologies with T2DM	0.55 (0.51–059)	0.60 (0.56–0.65)
NASH with T2DM vs other etiologies without T2DM	0.84 (0.79–0.89)	0.73 (0.68–0.78)
NASH without T2DM vs other etiologies with T2DM	0.33 (0.30–0.35)	0.40 (0.37–0.44)
NASH without T2DM vs other etiologies without T2DM	0.50 (0.46–0.54)	0.49 (0.45–0.53)
Other etiologies with T2DM vs other etiologies without T2DM	1.53 (1.47–1.59)	1.21 (1.16–1.26)

CI, Confidence interval; OR, Odds ratio; HCC, Hepatocellular carcinoma; T2DM, Type 2 diabetes mellitus; NASH, Nonalcoholic steatohepatitis.